Health ❯ Diabetes

Treatment Options

Medications GLP-1 Medications Insulin Medication Injectable Medications FDA Approval GLP-1 Drugs Weight Management Drug Efficacy GLP-1 Agonists Dipeptidyl Peptidase-4 Inhibitors Oral Medications Semaglutide Weight Loss Drugs GLP-1 Receptor Agonists

Biomea Fusion Reports Positive 52-Week Phase II Results for Icovamenib in Diabetes

Company-presented ATTD findings will guide dosing decisions for follow-on Phase II trials targeting defined patient groups.

Lilly Signs Up to $1.12 Billion Gene-Editing Pact to Tackle Hearing Loss

GLP-1 Drugs Linked to Lower Cancer Risk and Mortality in New Study

Blog Jobs Terms of Service Privacy Policy Cookies Help Partners About Us Copyright © 2026 Mina Labs, Inc.

We value your privacy

We and our partners use cookies and similar technologies to understand how you use our site and to show you personalized advertisements on other platforms. By clicking "Accept All," you consent to these technologies for advertising, analytics and retargeting. Click "Decline All" to opt out of non-essential cookies. You can learn more in our Privacy Policy.